Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Beclometasone is a corticosteroid medication used primarily for the treatment of asthma, allergic rhinitis, and certain skin conditions. It works by reducing inflammation in the airways and other affected tissues. As a glucocorticoid, it binds to glucocorticoid receptors, up-regulating anti-inflammatory proteins and repressing pro-inflammatory proteins, which helps decrease swelling and irritation in the airways to allow for easier breathing.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on beclometasone.